Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats

Addiction Biology

Volumn 12, Issue 3-4, 2007, Pages 470-477

  Li, Yi ^a,b   Liu, Xuebing ^a,b   Chen, Hongxian ^a   Deng, Huiqiong ^a   Xiang, Xiaojun ^a   Chen, Hanhui ^a   Hao, Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Conditioned place aversion; Extinction; Morphine; Negative reinforcement; Reinstatement; Withdrawal

Indexed keywords

MORPHINE; NALOXONE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; CONDITIONED PLACE AVERSION; CONDITIONING; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; MALE; MATHEMATICAL MODEL; MORPHINE ADDICTION; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; AVOIDANCE LEARNING; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; INJECTIONS, INTRAPERITONEAL; MALE; MENTAL RECALL; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SOCIAL ENVIRONMENT; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34547569296     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2007.00059.x     Document Type: Article

References (57)

1. Ahmed SH, Walker JR, Koob GF (2000) Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22: 413 421.
2. Azar MR, Jones BC, Schulteis G (2003) Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology 170: 42 50.
3. Bechara A (2003) Risky business: emotion, decision-making, and addiction. J Gambl Stud 19: 23 51.
4. Bechara A, Nader K, van der KD (1995) Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal. Behav Neurosci 109: 91 105.
5. Berke JD, Hyman SE (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515 532.
6. Bolla KI, Cadet JL, London ED (1998) The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci 10: 280 289.
7. Brown RA, Kahler CW, Zvolensky MJ, Lejuez CW, Ramsey SE (2001) Anxiety sensitivity: relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. Addict Behav 26: 887 899.
8. Caille S, Rodriguez-Arias M, Minarro J, Espejo EF, Cador M, Stinus L (2003) Changes in dopaminergic neurotransmission do not alter somatic or motivational opiate withdrawal-induced symptoms in rats. Behav Neurosci 117: 995 1005.
9. Chambers RA, Self DW (2002) Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia. Neuropsychopharmacology 27: 889 905.
10. Chiamulera C, Borgo C, Falchetto S, Valerio E, Tessari M (1996) Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology 127: 102 107.
11. Clark L, Robbins T (2002) Decision-making deficits in drug addiction. Trends Cogn Sci 6: 361.
12. Davis M, Walker DL, Myers KM (2003) Role of the amygdala in fear extinction measured with potentiated startle. Ann N Y Acad Sci 985: 218 232.
13. Egan MF, Wing L, Li R, Kirch DG, Wyatt RJ (1994) Effects of chronic cocaine treatment on rat brain: long-term reduction in frontal cortical serotonin. Biol Psychiatry 36: 637 640.
14. Everitt BJ, Dickinson A, Robbins TW (2001) The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev 36: 129 138.
15. Gracy KN, Dankiewicz LA, Koob GF (2001) Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24: 152 160.
16. Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474: 364 368.
17. Heinrichs SC, Menzaghi R, Schulteis G, Koob GF, Stinus L (1995) Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6: 74 80.
18. Higgins GA, Nguyen P, Sellers EM (1992) The NMD A antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci 50: L167 L172.
19. Hyman SE (2005) Addiction: a disease of learning and memory. Am J Psychiatry 162: 1414 1422.
20. Hyman SE, Malenka RC (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695 703.
21. LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA (1998) Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20: 937 945.
22. Laviolette SR, Nader K, van der KD (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129: 17 29.
23. Lewis MJ (1990) Alcohol: mechanisms of addiction and reinforcement. Adv Alcohol Subst Abuse 9: 47 66.
24. Liu X, Li Y, Zhou L, Chen H, Su Z, Hao W (2005) Conditioned place preference associates with the mRNA expression of diazepam binding inhibitor in brain regions of the addicted rat during withdrawal. Brain Res Mol Brain Res 137: 47 54.
25. Lu L, Ceng X, Huang M (2000) Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. Neuroreport 11: 2373 2378.
26. Lu L, Zhang B, Liu Z, Zhang Z (2002) Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats. Brain Res 954: 132 140.
27. McKee SA, Wall AM, Hinson RE, Goldstein A, Bissonnette M (2003) Effects of an implicit mood prime on the accessibility of smoking expectancies in college women. Psychol Addict Behav 17: 219 225.
28. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261: 669 677.
29. Mucha RF (1987) Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 418: 214 220.
30. Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86: 274 280.
31. Mueller D, Stewart J (2000) Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115: 39 47.
32. Myers KM, Davis M (2002) Behavioral and neural analysis of extinction. Neuron 36: 567 584.
33. Parker LA, Mcdonald RV (2000) Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes. Pharmacol Biochem Behav 66: 559 561.
34. Pihl RO, Finn P, Peterson J (1989) Autonomic hyperreactivity and risk for alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 13: 489 496.
35. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247 291.
36. Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 (Suppl. 2 S91 S117.
37. Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96: 103 114.
38. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54: 25 53.
39. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JF, Sahakian BJ, Robbins TW (1999) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322 339.
40. Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11: 2 38.
41. Santini E, Muller RU, Quirk GJ (2001) Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J Neurosci 21: 9009 9017.
42. Schechter MD, Calcagnetti DJ (1998) Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography. Neurosci Biobehav Rev 22: 827 846.
43. Shaham Y, Rodaros D, Stewart J (1994) Reinstatement of heroin-reinforced behavior following long-term extinction: implications for the treatment of relapse to drug taking. Behav Pharmacol 5: 360 364.
44. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168: 3 20.
45. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1 42.
46. Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, Nestler EJ (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci 22: 3663 3672.
47. Stinus L, Cador M, Zorrilla EP, Koob GF (2005) Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30: 90 98.
48. Stinus L, Caille S, Koob GF (2000) Opiate withdrawal-induced place aversion lasts for up to 16 weeks. Psychopharmacology 149: 115 120.
49. Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37: 767 773.
50. Swartzentruber D (1991) Blocking between occasion setters and contextual stimuli. J Exp Psychol Anim Behav Process 17: 163 173.
51. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56: 613 672.
52. Valverde O, Tzavara E, Hanoune J, Roques BP, Maldonado R (1996) Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal. Eur J Neurosci 8: 2671 2678.
53. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L (1992) Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11: 184 190.
54. Wang B, Luo F, Zhang WT, Han JS (2000) Stress or drug priming induces reinstatement of extinguished conditioned place preference. Neuroreport 11: 2781 2784.
55. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M (2002) Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 88: 399 406.
56. White DA, Hwang ML, Holtzman SG (2005) Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. Pharmacol Biochem Behav 81: 451 458.
57. Wilson WJ (1991) Negative reinforcement. Science 254: 1566 1567.